Shilpa Medicare's Q3 FY 2025-26 Quarterly Results
- 07 Feb 2026
Result Summary
- Shilpa Medicare Ltd reported a 10.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 28.1%.
- Its expenses for the quarter were up by 9.5% QoQ and 20.5% YoY.
- The net profit increased 1.2% QoQ and increased 40.3% YoY.
- The earnings per share (EPS) of Shilpa Medicare Ltd stood at 2.36 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 410.54 | 371.72 | 320.45 | 10.4% | 28.1% |
Total Expenses | 336.47 | 307.18 | 279.18 | 9.5% | 20.5% |
Profit Before Tax | 61.21 | 64.54 | 41.27 | -5.2% | 48.3% |
Tax | 16.27 | 20.36 | 9.83 | -20.1% | 65.5% |
Profit After Tax | 44.58 | 44.07 | 31.78 | 1.2% | 40.3% |
Earnings Per Share | 2.36 | 2.25 | 3.25 | 4.9% | -27.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Shilpa Medicare Ltd is a pharmaceutical company known for its extensive range of generic formulations, custom synthesis for global pharmaceutical companies, and active pharmaceutical ingredients (APIs). The company operates within the healthcare and pharmaceutical industry, focusing on producing and distributing high-quality medicines. Shilpa Medicare has been actively involved in research and development to expand its product offerings and improve its manufacturing processes. Recent major developments for the company are not specified in the data provided.
Revenue
In Q3FY26, Shilpa Medicare Ltd reported a total income of ₹410.54 crores, marking a 10.4% increase compared to ₹371.72 crores in Q2FY26. This growth is even more pronounced on a year-over-year basis, with a 28.1% increase from ₹320.45 crores in Q3FY25. The substantial YoY growth indicates a significant increase in the company's revenue generation capabilities over the past year.
Profitability
The company's Profit Before Tax (PBT) for Q3FY26 stood at ₹61.21 crores, which represents a decrease of 5.2% from ₹64.54 crores in the previous quarter, Q2FY26. However, on a year-over-year basis, there was an increase of 48.3% from ₹41.27 crores in Q3FY25. Tax expenses were ₹16.27 crores in Q3FY26, a decrease of 20.1% from the previous quarter but an increase of 65.5% compared to the same quarter last year. The Profit After Tax (PAT) for Q3FY26 was ₹44.58 crores, showing a marginal increase of 1.2% QoQ from ₹44.07 crores and a significant YoY growth of 40.3% from ₹31.78 crores in Q3FY25.
Operating Metrics
Earnings Per Share (EPS) for Q3FY26 was ₹2.36, reflecting an increase of 4.9% from ₹2.25 in Q2FY26, although it shows a decline of 27.4% from ₹3.25 in Q3FY25. Total expenses in Q3FY26 were ₹336.47 crores, up 9.5% from ₹307.18 crores in the previous quarter and 20.5% from ₹279.18 crores in the same quarter the previous year. These financial figures highlight the cost dynamics and revenue efficiency of the company's operations over the periods in question.